Correction to: Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin (Biomedicines, (2021), 9, 6, (650), 10.3390/biomedicines9060650)

Štorkánová H, Štorkánová L, Navrátilová A, Bečvář V, Hulejová H, Oreská S, Heřmánková B, Špiritović M, Bečvář R, Pavelka K, Vencovský J, Distler J, Šenolt L, Tomčík M (2023)

Publication Type: Journal article, Erratum

Publication year: 2023

Journal

Biomedicines MDPI AG

Book Volume: 11

Article Number: 2736

Journal Issue: 10

DOI: 10.3390/biomedicines11102736

Abstract

In the original publication [1], there was a mistake in Figure 4 as published. The representative picture of the immunohistochemistry staining for aSMA of the group entitled BLM (w1-6) + nintedanib (w4-6) was erroneously selected from a different group of mice. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Authors with CRIS profile

Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

Involved external institutions

Univerzita Karlova v Praze / Charles University in Prague CZ Czech Republic (CZ)

How to cite

APA:

Štorkánová, H., Štorkánová, L., Navrátilová, A., Bečvář, V., Hulejová, H., Oreská, S.,... Tomčík, M. (2023). Correction to: Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin (Biomedicines, (2021), 9, 6, (650), 10.3390/biomedicines9060650). Biomedicines, 11(10). https://doi.org/10.3390/biomedicines11102736

MLA:

Štorkánová, Hana, et al. "Correction to: Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin (Biomedicines, (2021), 9, 6, (650), 10.3390/biomedicines9060650)." Biomedicines 11.10 (2023).

BibTeX: Download